[1]
|
Hyuna, S., Jacques, F., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
胡洋洋, 肖滢, 罗越, 等. 《原发性肝癌三级预防共识(2022年版)》解读[J]. 河北医科大学学报, 2023, 44(11): 1241-1247. http://kns.cnki.net/kcms/detail/13.1209.R.20231204.2209.002.html
|
[3]
|
Mauro, G., Enrico, Z., Alessia, V., et al. (2022) Predictors of Hepatocellular Carcinoma Early Recurrence in Patients Treated with Surgical Resection or Ablation Treat-ment: A Single-Center Experience. Diagnostics, 12, Article 2517.
https://doi.org/10.3390/diagnostics12102517
|
[4]
|
Manon, A., Marika, R. and Dominique, T. (2021) Portal Hyper-tension and Hepatocellular Carcinoma: Des Liaisons Dangereuses… Liver International, 41, 1734-1743. https://doi.org/10.1111/liv.14977
|
[5]
|
Stukan, M. (2017) Drainage of Malignant Ascites: Patient Selection and Perspectives. Cancer Management and Research, 9, 115-130. https://doi.org/10.2147/CMAR.S100210
|
[6]
|
樊红杰, 姚荣妹, 许春艳, 等. 脐灸结合腹腔内用药治疗癌性腹水疗效研究[J]. 中国中医药现代远程教育, 2012, 10(5): 34-35.
|
[7]
|
吕书勤, 凌昌全. 浅析肝癌与“湿” [J]. 天津中医药, 2004(2): 134-136.
|
[8]
|
张亚玲, 郑玉玲, 陈晓琦. 郑玉玲健脾援肝法治疗肝癌腹水经验[J]. 国医论坛, 2021, 36(2): 46-48.
https://doi.org/10.13913/j.cnki.41-1110/r.2021.02.020
|
[9]
|
张云瑞, 赵一举. 疏肝健脾逐水汤治疗原发性肝癌腹水临床观察[J]. 光明中医, 2020, 35(14): 2180-2182.
|
[10]
|
宋凤丽, 康宁, 王文雯, 等. 中医药治疗恶性腹水证候及用药规律分析[J]. 中医学报, 2018, 33(12): 2298-2303.
https://doi.org/10.16368/j.issn.1674-8999.2018.12.542
|
[11]
|
骆嘉华, 刘振海, 李增辉. 真武汤联合腹腔化疗治疗脾肾阳虚型癌性腹水的临床效果[J]. 中国当代医药, 2018, 25(11): 145-147.
|
[12]
|
唐亚乐, 韩涛. 保肝利水汤治疗阴虚水停型原发性肝癌腹水临床观察[J]. 中国中医药现代远程教育, 2022, 20(3): 100-102.
|
[13]
|
张庆林, 刘丽星, 王耀焓, 等. “平衡阻断”法治疗恶性腹水经验探析[J]. 北京中医药, 2018, 37(12): 1157-1159.
https://doi.org/10.16025/j.1674-1307.2018.12.015
|
[14]
|
田明敏. 黄煌运用黄芩汤、五苓散治疗肝癌腹水临床经验[J]. 上海中医药杂志, 2018, 52(4): 32-34.
https://doi.org/10.16305/j.1007-1334.2018.04.009
|
[15]
|
张帆, 陈斌, 伍玉南, 等. 十枣散外敷治疗湿热血瘀型肝癌并腹水的临床研究[J]. 时珍国医国药, 2020, 31(3): 633-635.
|
[16]
|
伍秉翔, 李开春, 沈原, 等. 中药外敷联合脐疗治疗癌性腹水36例的临床观察[J]. 中医外治杂志, 2023, 32(2): 61-63.
|
[17]
|
王洁. 中药塌渍配合红外线照射治疗肝癌相关性腹水的回顾性队列研究[D]: [硕士学位论文]. 长春: 长春中医药大学, 2022. https://doi.org/10.26980/d.cnki.gcczc.2021.000115
|
[18]
|
江烽, 洪芦鱼, 曾水成. 中药脐疗联合艾灸治疗恶性腹腔积液的临床研究[J]. 中外医学研究, 2020, 18(6): 133-135. https://doi.org/10.14033/j.cnki.cfmr.2020.06.056
|
[19]
|
曹玉婵, 田叶红, 张巧丽, 等. 针灸治疗恶性腹腔积液的临床经验[J]. 环球中医药, 2020, 13(5): 880-882.
|
[20]
|
田岳凤, 李雷勇, 金晓蝉. 隔物灸中穴、药、灸作用方式及作用机制分析[J]. 山西中医学院学报, 2018, 19(6): 39-41.
|
[21]
|
周永红, 张风宾, 赵飞. 康莱特注射液联合顺铂腹腔灌注治疗胃癌恶性腹腔积液的效果观察[J]. 吉林医学, 2019, 40(8): 1821-1823.
|
[22]
|
王媛. 复方苦参注射液配合腹腔灌注化疗治疗卵巢癌腹腔积液临床研究[J]. 中国中医药信息杂志, 2015, 22(5): 25-28.
|
[23]
|
陆佩知, 徐丽, 杨会张, 等. 鸦胆子油注射液联合氟尿嘧啶及顺铂热灌注化疗治疗恶性腹腔积液的疗效观察[J]. 中国继续医学教育, 2016, 8(21): 167-168.
|
[24]
|
王一同, 周琴, 郑俊超, 等. 华蟾素注射液灌注治疗恶性血性胸腹腔积液的疗效评价及优势人群研究[J]. 现代中西医结合杂志, 2020, 29(30): 3313-3317, 3326.
|
[25]
|
Zhang, R.R., Shao, M.Y., Fu, Y., et al. (2023) Benefit-Risk Assessment of Chinese Medicine Injections for Primary Liver Cancer Based on Mul-ti-Criteria Decision Analysis. Chinese Journal of Integrative Medicine.
|
[26]
|
刘会岭, 陈兴秀, 蔡小萍, 等. 恶性腹腔积液的分子机制及治疗进展[J]. 消化肿瘤杂志(电子版), 2018, 10(4): 179-182.
|
[27]
|
秦叔逵, 马军, 李进, 等. 重组改构人肿瘤坏死因子治疗恶性胸、腹腔积液的临床应用专家共识[J]. 临床肿瘤学杂志, 2018, 23(1): 67-72.
|
[28]
|
张巍, 刘代顺. 恶性胸腔积液分子机制的研究进展[J]. 现代医药卫生, 2016, 32(7): 1009-1011.
|
[29]
|
秦叔逵, 李进, 韩宝惠, 等. 重组人血管内皮抑制素治疗恶性浆膜腔积液临床应用专家共识[J]. 临床肿瘤学杂志, 2020, 25(9): 849-856.
|
[30]
|
Reddy, R.A., Varshini, M.S. and Kumar, R.S. (2023) Matrix Metalloproteinase-2 (MMP-2): As an Es-sential Factor in Cancer Progression. Recent Patents on Anti-Cancer Drug Discovery.
|
[31]
|
Ahmed, Z.R. and Bardaweel, S.K. (2023) Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment. International Journal of Molec-ular Sciences, 24, Article 12133. https://doi.org/10.3390/ijms241512133
|
[32]
|
贾琳. VEGF-A, C, D作为恶性浆膜脸积液诊断、预后及疗效预测标志物的研究[D]: [博士学位论文]. 石家庄: 河北医科大学, 2014.
|
[33]
|
Kipps, E., Tan, D.S.P. and Kaye, S.B. (2013) Meeting the Challenge of Ascites in Ovarian Cancer: New Avenues for Therapy and Research. Nature Reviews Cancer, 13, 273-282. https://doi.org/10.1038/nrc3432
|
[34]
|
Tan, H.W., Wang, S.Y. and Zhao, L.D. (2017) A Tumour-Promoting Role of Th9 Cells in Hepatocellular Carcinoma through CCL20 and STAT3 Pathways. Clinical and Experimental Pharmacology & Physiology, 44, 213-221.
https://doi.org/10.1111/1440-1681.12689
|
[35]
|
刘淳. 恶性腹水的诊断与控制研究进展[J]. 中国现代医生, 2012, 50(19): 29-31.
|
[36]
|
王磊. 肾素-血管紧张素-醛固酮系统与门静脉高压症[J]. 国外医学(消化系疾病分册), 2002, 22(1): 45-47.
|
[37]
|
Thadi, A., Khalili, M., Morano, W.F., et al. (2018) Early Investigations and Recent Advances in In-traperitoneal Immunotherapy for Peritoneal Metastasis. Vaccines, 6, Article 54. https://doi.org/10.3390/vaccines6030054
|
[38]
|
秦叔逵, 刘秀峰, 马军, 等. 注射用重组改构人肿瘤坏死因子治疗国人恶性胸、腹腔积液的前瞻性多中心临床研究[J]. 临床肿瘤学杂志, 2016, 21(7): 577-584.
|
[39]
|
贺玉卿, 高立明, 高庆壮, 等. 腹腔灌注重组人血管内皮抑素联合洛铂射频热疗对恶性腹腔积液患者VEGF及生活质量的影响[J]. 实用临床医药杂志, 2016, 20(5): 53-56.
|
[40]
|
周云凤, 廖新民, 刘洋, 等. 深部热疗联合腔内灌注化疗对恶性胸腹水患者疗效及生活质量的影响[J]. 肿瘤药学, 2017, 7(4): 421-424, 435.
|
[41]
|
李雁, 周云峰, 梁寒, 等. 细胞减灭术加腹腔热灌注化疗治疗腹膜表面肿瘤的专家共识[J]. 中国肿瘤临床, 2015(4): 198-206. https://doi.org/10.3969/j.issn.1000-8179.20150013
|
[42]
|
Parissa, T., Bernardo, F., Ghalib, J., et al. (2014) Cytore-ductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Hepatocellular Carcinoma. Journal of Surgical Oncology, 110, 786-790.
https://doi.org/10.1002/jso.23739
|
[43]
|
Nicolas, G., Naoual, B., Guillaume, P., et al. (2012) Iterative Procedures Combining Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Recurrence: Postoper-ative and Long-Term Results. Journal of Surgical Oncology, 106, 197-203. https://doi.org/10.1002/jso.23062
|
[44]
|
Alvaro, A., Cristobal, M., Rosa, O., et al. (2014) Long-Term Survival with Peritoneal Mucinous Carcinomatosis from Intraductal Mucinous Papillary Pancreatic Carcinoma Treated with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy. International Journal of Hyperthermia, 30, 408-411.
https://doi.org/10.3109/02656736.2014.952251
|
[45]
|
陈观源, 陈小铭, 李震东. 腹腔热灌注化疗在肝癌治疗中的研究进展[J]. 肝胆胰外科杂志, 2021, 33(11): 701-705.
|
[46]
|
任洪成, 王斌, 邵长刚, 等. 不同支架肝静脉端形态对经颈静脉肝内门体分流术后疗效的影响[J]. 介入放射学杂志, 2023, 32(10): 1001-1005.
|
[47]
|
Daniele, B., Michele, M., Federico, B.D., et al. (2023) The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular Carcinoma. Medicina, 59, Article 1150.
https://doi.org/10.3390/medicina59061150
|
[48]
|
Ito, T. and Hanafusa, N. (2017) CART: Cell-free and Concentrated Ascites Reinfusion Therapy against Malignancy-Related Ascites. Transfusion and Apheresis Science, 56, 703-707. https://doi.org/10.1016/j.transci.2017.08.018
|
[49]
|
Charlotte, K., Johan, W., Anja, H., et al. (2006) Population Pharmacokinetic-Pharmacodynamic Model for Neutropenia with Patient Subgroup Identification: Comparison across An-ticancer Drugs. Clinical Cancer Research, 12, 5481-5490.
https://doi.org/10.1158/1078-0432.CCR-06-0815
|
[50]
|
Hao, C., Masashi, I., Nobuyuki, H., et al. (2021) Effective-ness of Cell-Free and Concentrated Ascites Reinfusion Therapy in the Treatment of Malignancy-Related Ascites: A Sys-tematic Review and Meta-Analysis. Cancers, 13, Article 4873. https://doi.org/10.3390/cancers13194873
|